Skip to content

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardcover - 2017 - 1st Edition

by Bredesen, Dale

  • Used
  • Hardcover

Description

Avery, 8/22/2017. Hardcover. Like New. 0x0x0. New with remainder mark. Multiple copies are available. Buy multiples from our store to save on shipping.
New
NZ$14.45
NZ$6.58 Shipping to USA
Standard delivery: 7 to 14 days
More Shipping Options
Ships from Beans Books, Inc. (Ohio, United States)

Details

  • Title The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline
  • Author Bredesen, Dale
  • Binding Hardcover
  • Edition number 1st
  • Edition 1
  • Condition New
  • Pages 320
  • Volumes 1
  • Language ENG
  • Publisher Avery
  • Date 8/22/2017
  • Illustrated Yes
  • Features Bibliography, Illustrated, Index
  • Bookseller's Inventory # 1908150017
  • ISBN 9780735216204 / 0735216207
  • Weight 1.05 lbs (0.48 kg)
  • Dimensions 9.1 x 6.2 x 1.3 in (23.11 x 15.75 x 3.30 cm)
  • Themes
    • Topical: Health & Fitness
  • Library of Congress subjects Alzheimer's disease - Prevention, Alzheimer's disease - Treatment
  • Library of Congress Catalog Number 2017029515
  • Dewey Decimal Code 616.831

About Beans Books, Inc. Ohio, United States

Biblio member since 2010
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

Add multiple items from ChristianBookbag to your cart to save with combined shipping fees. ChristianBookbag has been selling books online since 2003. We specialize in Christian material, and have over 9000 titles.

Terms of Sale:

30 day return guarantee, with full refund including shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from Beans Books, Inc.

About the author

Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.